Understanding Incidence Rate in B2B Research: Why a 20% IR Isn't What You Think
Incidence rate in B2B research is one of the most misunderstood metrics in the industry — with direct consequences for project budgeting, timeline planning, and sample quality assessment.
Incidence rate (IR) is the single most important number in a B2B research feasibility discussion — and the one most frequently misunderstood or optimistically estimated by panel providers under competitive pressure. A 20% IR claim sounds reasonable. What it actually represents can vary enormously depending on how it is measured and what it reveals about sample quality.
What Incidence Rate Actually Measures
IR is the percentage of respondents who complete a screener and qualify for the main survey. A 20% IR means that for every 100 people who start the screener, 20 meet the qualifying criteria. The complication is that IR can be calculated at different points in the respondent funnel — among all respondents invited, those who complete the screener, or those who complete it without being flagged for quality reasons. These produce different numbers, and providers aren't always transparent about which one they're quoting.
Why Unusually High IR Is a Warning Sign
For senior B2B targets, realistic IR is often lower than research teams want to hear:
- General business professionals (any seniority): 40–60% IR is plausible
- Senior professionals (VP+) in defined industries: 10–25% IR is realistic
- C-suite in specific company size ranges: 5–15% IR is expected
- Low-incidence specialists (e.g., board-certified oncologists): 2–8% IR is typical
IR and Sample Contamination: The Direct Relationship
The mechanism producing artificially high IR in B2B research is the same producing sample contamination: professional respondents who have learned to answer screeners correctly. This creates an inverse relationship between IR accuracy and sample quality. A panel rigorously verifying professional credentials will produce lower IRs (because unqualified respondents are filtered before screeners) but higher data quality. A screener-only panel produces higher IRs and lower data quality.
Using IR as a Quality Signal in Provider Evaluation
The questions to ask any panel provider:
- How do you calculate IR — at what point in the respondent funnel?
- What is your typical IR for this target audience, and what methodology produces it?
- How does your IR calculation account for respondents flagged by fraud detection?
- Can you show comparable IR data from similar completed studies?
TFSurvey delivers verified B2B and healthcare professional respondents with CalibraSync fraud prevention. Request a feasibility study within 24 hours.
Request Feasibility Study ↑